Skip to main content
. 2008 Apr;152(1):50–56. doi: 10.1111/j.1365-2249.2008.03598.x

Fig. 1.

Fig. 1

Comparison of soluble human leucocyte antigen (sHLA) class I level in without acute graft-versus-host disease patients (n = 7) between the first month post-allograft (days 0–30) and the third month post transplantation (days 60–90). sHLA class I level is increased significantly in the third month post allograft [Wilcoxon's matched-pairs test: P < 0·05 (*)].